Prevalence and relationship with health of off-label and contraindicated drug use in the United States: a cross-sectional study
Background: Off-label and contraindicated prescription drug use can result in adverse health outcomes. Despite concerns, the extent and characteristics of such usage patterns remain underexplored in the American population. We conducted a cross-sectional study analysing outpatient prescription data...
Saved in:
| Main Authors: | Katharina E. Blankart, Frank R. Lichtenberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2025.2472221 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
“Off-label” drugs: legal problems and socio-economic aspects of application practice
by: S. V. Russkikh, et al.
Published: (2023-08-01) -
Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01) -
Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01) -
Off-label antibiotic use in a specialized children care hospital in Punjab, Pakistan: Findings and implications
by: Muhammad Hafeez, et al.
Published: (2020-05-01) -
Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01)